Bank of New York Mellon »

Lucid Diagnostics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Lucid Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Lucid Diagnostics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lucid Diagnostics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2025-09-30 $208k 206k 1.01
2025-06-30 $180k 157k 1.15

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Cl A (GOOGL)
Alphabet CL C (GOOG)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Exxon Mobil Corporation (XOM)
Mastercard Inc - A Cl A (MA)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Lucid Diagnostics

Vanguard Group
Masters Capital Mgmt
BlackRock
Two Seas Capital
AWM Investment Company
Ghisallo Capital Management
Standard Life Aberdeen
Geode Capital Management
Alyeska Investment Group
Perkins Capital Management
State Street Corporation
Luminus Management
Wells Fargo & Company
Goldman Sachs Group
Northern Trust

View all funds holding Lucid Diagnostics